Zhang Hongling, Liu Zhengdong, Shu Huaqing, Yu Yuan, Yang Xiaobo, Li Ruiting, Xu Jiqian, Zou Xiaojing, Shang You
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Department of Intensive Care Unit, Affiliated Lu'an Hospital, Anhui Medical University, Lu'an, 237000, China.
J Intensive Care. 2022 Oct 4;10(1):46. doi: 10.1186/s40560-022-00640-5.
Acute respiratory distress syndrome (ARDS), a prevalent cause of admittance to intensive care units, is associated with high mortality. Prone positioning has been proven to improve the outcomes of moderate to severe ARDS patients owing to its physiological effects. Venovenous extracorporeal membrane oxygenation (VV ECMO) will be considered in patients with severe hypoxemia. However, for patients with severe hypoxemia supported with VV ECMO, the potential effects and optimal strategies of prone positioning remain unclear. This review aimed to present these controversial questions and highlight directions for future research.
The clinically significant benefit of prone positioning and early VV ECMO alone was confirmed in patients with severe ARDS. However, a number of questions regarding the combination of VV ECMO and prone positioning remain unanswered. We discussed the potential effects of prone positioning on gas exchange, respiratory mechanics, hemodynamics, and outcomes. Strategies to achieve optimal outcomes, including indications, timing, duration, and frequency of prone positioning, as well as the management of respiratory drive during prone positioning sessions in ARDS patients receiving VV ECMO, are challenging and controversial. Additionally, whether and how to implement prone positioning according to ARDS phenotypes should be evaluated. Lung morphology monitored by computed tomography, lung ultrasound, or electrical impedance tomography might be a potential indication to make an individualized plan for prone positioning therapy in patients supported with VV ECMO.
For patients with ARDS supported with VV ECMO, the potential effects of prone positioning have yet to be clarified. Ensuring an optimal strategy, especially an individualized plan for prone positioning therapy during VV ECMO, is particularly challenging and requires further research.
急性呼吸窘迫综合征(ARDS)是重症监护病房收治患者的常见病因,与高死亡率相关。俯卧位通气因其生理效应已被证明可改善中重度ARDS患者的预后。对于严重低氧血症患者,可考虑采用静脉-静脉体外膜肺氧合(VV ECMO)治疗。然而,对于接受VV ECMO支持的严重低氧血症患者,俯卧位通气的潜在效果和最佳策略仍不明确。本综述旨在提出这些有争议的问题,并突出未来研究方向。
在重度ARDS患者中,俯卧位通气和早期单独使用VV ECMO的临床显著益处已得到证实。然而,关于VV ECMO与俯卧位通气联合使用的一些问题仍未得到解答。我们讨论了俯卧位通气对气体交换、呼吸力学、血流动力学和预后的潜在影响。在接受VV ECMO的ARDS患者中,实现最佳预后的策略,包括俯卧位通气的指征、时机、持续时间和频率,以及俯卧位通气期间呼吸驱动的管理,具有挑战性且存在争议。此外,应评估是否以及如何根据ARDS表型实施俯卧位通气。通过计算机断层扫描、肺部超声或电阻抗断层扫描监测的肺形态可能是为接受VV ECMO支持的患者制定个性化俯卧位通气治疗方案的潜在指征。
对于接受VV ECMO支持的ARDS患者,俯卧位通气的潜在效果尚未明确。确保最佳策略,尤其是在VV ECMO期间进行个性化俯卧位通气治疗方案,极具挑战性,需要进一步研究。